Jill Kremer

Jill Kremer has extensive work experience in the medical field, particularly in clinical development and research. Jill is currently serving as the Medical Director of Clinical Development at Taiho Oncology, Inc. since March 2020. Prior to that, they worked as a Clinical Research Physician at Eli Lilly and Company from July 2018 to March 2020. Before joining Eli Lilly, Jill was a Developmental Therapeutics Fellow at Indiana University School of Medicine & Eli Lilly & Co. from July 2016 to June 2018. Earlier in their career, they held positions as a Hematology/Oncology Fellow and a Resident Physician at Indiana University School of Medicine from July 2014 to July 2017 and from June 2011 to June 2014, respectively.

Jill Kremer's education history began in 2007 at Wayne State University, where they pursued a Doctor of Medicine (MD) degree until 2011. Following this, from 2011 to 2018, Jill attended Indiana University School of Medicine, though the specific degree and field of study achieved during this period are not provided.